Home

George Gallate Joins the Board of Life Science Connect to Enhance Strategic Marketing Capabilities

via Business Wire

Life Science Connect (or “LSC”) is pleased to announce the appointment of George Gallate to its Board of Directors. LSC is a portfolio Company of Latticework Capital Management and Edgehill Management.

LSC, headquartered in Pittsburgh, Pennsylvania, is an intelligent, data-driven platform designed for B2B connection, collaboration, and contribution. As a leader in digital media for the life sciences, LSC is committed to enhancing professional connections within the sector to accelerate research, development, manufacturing, and the application of scientific innovations.

With a career spanning over 40 years combining media, data, technology, and creativity to drive business growth, Mr. Gallate is a highly experienced marketing executive recognized for building and leading some of the world’s largest digital and integrated marketing networks. As the former Global Chairman and CEO of Havas Digital (formerly Euro RSCG 4D), Mr. Gallate was instrumental in forming and scaling the network into a global leader, recognized by Adweek as the largest digital agency network for five consecutive years. Mr. Gallate also served as regional CEO for Havas across Asia Pacific, India, and the Middle East, and later held key leadership positions at RKG (Rimm-Kaufman Group), successfully negotiating its sale to Merkle, where he became CMO and Global EVP. He currently serves as CEO of MKTG2.U and was a highly engaged board director involved with the growth and successful exits of Tinuiti, W2O (now Real Chemistry), Bounteous and Mars United Commerce. He continues to sit on the boards of Tinuiti, Real Chemistry and Bounteous and also serves on the boards of Vytalogy, WebFX, Bond Loyalty, Horizon Services, and Anteriad.

Mr. Gallate has already been an impactful strategic partner to LSC. His experience in cultivating integrated digital marketing networks has provided substantial insight in forming LSC’s vision of the value add it can bring its readers and clients in the pharma services industry.

“Life Science Connect is a leader in their field,” said Mr. Gallate. “They have strong community engagement given the quality and value of their content. The quality of their content also attracts and keeps high value subscribers. Together, this means they enjoy strong growth and retention of their clients. It’s one of the best value driven marketing ecosystems I’ve seen. I was excited to join their board as their new financial partner. Latticework Capital has a track record of working with quality companies to drive growth and value.”

“We’re excited to welcome George Gallate to the Life Science Connect Board of Directors,” said Jon Howland, CEO of LSC. “George is a proven leader in global marketing and communications. His deep expertise in building and leading world-class agencies, coupled with his ability to guide major healthcare and technology brands through transformative growth, will bring invaluable perspective as Life Science Connect continues to strengthen its role as the leading voice in the life sciences industry.”

LSC is actively seeking acquisition and growth opportunities to help expand their suite of capabilities for B2B sales and marketing enablement and to reach new audiences. Please contact Jon Howland (jon.howland@lifescienceleader.com) to connect further regarding a potential acquisition.

About Life Science Connect

Life Science Connect is a network of life science go-to-work solutions dedicated to a better way of connecting professionals across life science communities to advance the pace of research, development, manufacturing, and use of life science innovations. Life Science Connect facilitates mutually beneficial connections between audiences and strategic partners that accelerate the advancement of life-improving, life-extending, and life-saving therapies and devices. LSC serves a loyal, professional readership that demands original, compelling content with professional applications and facilitates engagement across the drug development lifecycle through leading digital publications, events, podcasts, and more. To learn more visit www.lifescienceconnect.com.

Contacts